Filing Details
- Accession Number:
- 0001596771-16-000115
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-02 16:26:50
- Reporting Period:
- 2016-06-01
- Filing Date:
- 2016-06-02
- Accepted Time:
- 2016-06-02 16:26:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1610092 | Diplomat Pharmacy Inc. | DPLO | Retail-Drug Stores And Proprietary Stores (5912) | 382063100 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1619008 | A Atheer Kaddis | 4100 S. Saginaw Street Flint MI 48507 | Evp Of Sales & Strategic Align | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-01 | 12,325 | $3.07 | 12,325 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-06-01 | 7,800 | $32.16 | 4,525 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-06-01 | 4,525 | $32.57 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option to Acquire Common Stock | Disposition | 2016-06-01 | 12,325 | $0.00 | 12,325 | $3.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
320,450 | 2019-04-01 | No | 4 | M | Direct |
Footnotes
- The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on August 6, 2015. The plan provides for monthly sales of 12,325 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. A maximum of 24,650 shares remain available for sale under the plan, which is set to expire on August 31, 2016.
- The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $31.80 to $32.49 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
- The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $32.50 to $32.84 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
- The options were granted on April 1, 2009. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 100% of the options originally granted are currently vested and exercisable.